X
Xilio Therapeutics, Inc. (XLO)
NCM – Real vaqt narxi. Valyuta: USD
8.32
-0.36 (-4.15%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.35
+0.03 (0.36%)
Bozordan keyin: Mar 27, 2026, 5:35 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
8.32
-0.36 (-4.15%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.35
+0.03 (0.36%)
Bozordan keyin: Mar 27, 2026, 5:35 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.20 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 2.20 | 5.63 | 10 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.05 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 6.2 | |||
| KO‘RSATKICH | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | 6M | 32M |
| Yalpi foyda | -1M | -2M | -2M | 5M | 30M |
| Operatsion daromad | -75M | -89M | -79M | -60M | -44M |
| Sof foyda | -76M | -88M | -76M | -58M | -58M |
| EBITDA | -74M | -87M | -77M | -58M | -42M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 532.25 | 65 | 10 |
| Keyingi chorak | 273.93 | 61.28 | 10 |
| Joriy yil | 546.28 | 55.05 | 10 |
| Keyingi yil | -7.8 | 38.78 | 5.5 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 135.85 | -2.79 | 31.25 | -17.58 | 5.5 |
| Yil/Yil | 742.51 | -16.16 | 50 | -27.87 | 5.5 |
| 3 yil o‘rtacha | 999 | 6.93 | 50.21 | 29.83 | 8.8 |
| 5 yil o‘rtacha | 999 | -47.08 | 50.21 | -26.11 | 5.5 |
| O‘rtacha ball | 6.3 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $103.8M umumiy qarzdan $7.3M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $124.1M jami joriy majburiyatlardan $56.4M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-0.9) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$17.5M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi